VYNT

Vyant Bio, Inc. Common Stock
VYNT

Overview Fund Activity
Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

29 hedge funds and large institutions have $19.8M invested in Vyant Bio, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 6 closing their positions.

Holders
29
Holders Change
+13
Holders Change %
+81.25%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
7
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DM
1
Deerfield Management
New York
$4.88M
2
DCM
2
Driehaus Capital Management
Illinois
$2.08M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.9M
4
GMCM
4
Gruber & McBaine Capital Management
California
$1.16M
5
PCM
5
Perkins Capital Management
Minnesota
$1.13M

Top Sellers

1
EI
1
EAM Investors
California
$0
2
Jane Street
2
Jane Street
New York
$0
3
NIP
3
Nicholas Investment Partners
California
$0
4
MA
4
MUFG Americas
New York
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$88K
Name Market Value Shares Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
$7K 488 +488 New
ASN
27
Advisory Services Network
Georgia
$7K 500 +500 New
MTIP
28
Magee Thomson Investment Partners
California
$6K 497 -159 -24%
Bank of America
29
Bank of America
North Carolina
$3K 200 +100 +100%
EI
30
EAM Investors
California
– – -45,222 Closed
Jane Street
31
Jane Street
New York
– – -27,548 Closed
NIP
32
Nicholas Investment Partners
California
– – -16,466 Closed
MA
33
MUFG Americas
New York
– – -16,200 Closed
MP
34
Manifold Partners
California
– – -1,050 Closed
Barclays
35
Barclays
United Kingdom
– – -600 Closed
1
2